26 results
Alteplase (t-PA) for Acute Ischemic Stroke: 
Dosage, Mixing, and Administration Instructions

#TPA #Thrombolytics #Stroke #CVA #Dosage #Dosing
Instructions #TPA #Thrombolytics ... #Stroke #CVA #Dosage ... #Dosing #Mixing ... #Instructions #Pharmacology
tPA Code Stroke Dosing Chart

Total Dose = 0.9 mg/kg (maximum dose =90 mg)
 - give 10%
tPA Code Stroke Dosing ... 1 hour #TPA #Dosing ... #Dose #CVA #Thrombolytics ... #Stroke #Pharmacology
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... Metformin #CKD3 #CKD4 #Dosing ... #Pharmacology #
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Metformin - First Line Treatment ... for Diabetes Type ... form and consider using ... Indications #Titration #Pharmacology ... #Diabetes #DM2
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... anti-infectives ... IV to PO anti-infectives ... #pharmacology #antibiotics ... medications #table #treatment
Nontuberculous mycobacteria (NTM) pulmonary disease treatment (pulmonary MAC)

By Dr. Sara Dong @swinndong via Febrile [febrilepodcast.com
Nontuberculous mycobacteria ... pulmonary disease treatment ... Sara Dong @swinndong ... Diseases #Infections ... #treatment #pulmonaryMAC
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... canagliflozin ↓ CV ... hypovolemia) • GU infections ... • Euglycemic diabetic ... #Summary #DM2 #diabetes
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... are subcutaneous injections ... GI tract) and injection ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... /day or weekly injection ... variety of adverse CV ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes
Metformin: Biguanide
Metformin is the first-line medication for treatment of type 2 diabetes. It is very effective
medication for treatment ... of type 2 diabetes ... 2000 mg/day) and using ... #Metformin #Pharmacology ... #Mechanism #Diabetes